AAAAAA
Results:
1-13
|
Results: 13
Authors:
LIEBMAN HA
ASHANI N
SUTHERLAND D
MCGEHEE W
KAM L
Citation: Ha. Liebman et al., THE FACTOR-V-LEIDEN MUTATION INCREASES THE RISK OF VENOUS THROMBOSIS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 115(4), 1998, pp. 830-834
Authors:
LIEBMAN HA
SUTHERLAND D
MCGEHEE W
Citation: Ha. Liebman et al., A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE IS ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 2159-2159
Authors:
WEITZ IC
ISRAEL VK
LIEBMAN HA
Citation: Ic. Weitz et al., TAMOXIFEN-ASSOCIATED VENOUS THROMBOSIS AND ACTIVATED PROTEIN-C RESISTANCE DUE TO FACTOR-V-LEIDEN, Cancer, 79(10), 1997, pp. 2024-2027
Authors:
LIEBMAN HA
SUTHERLAND D
BACON R
MCGEHEE W
Citation: Ha. Liebman et al., EVALUATION OF A TISSUE FACTOR-DEPENDENT FACTOR-V ASSAY TO DETECT FACTOR-V LEIDEN - DEMONSTRATION OF HIGH-SENSITIVITY AND SPECIFICITY FOR A GENERALLY APPLICABLE ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE, British Journal of Haematology, 95(3), 1996, pp. 550-553
Authors:
ROCHAT J
MORBACHER A
LIEBMAN HA
Citation: J. Rochat et al., A PARAPROTEIN FACTOR-VIII INHIBITOR IN A PATIENT WITH LIGHT-CHAIN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 133-133
Authors:
GILL PS
ESPINA BM
MUGGIA F
CABRIALES S
TULPULE A
ESPLIN JA
LIEBMAN HA
FORSSEN E
ROSS ME
LEVINE AM
Citation: Ps. Gill et al., PHASE I II CLINICAL AND PHARMACOKINETIC EVALUATION OF LIPOSOMAL DAUNORUBICIN/, Journal of clinical oncology, 13(4), 1995, pp. 996-1003
Authors:
GILL PS
HARRINGTON W
KAPLAN MH
RIBEIRO RC
BENNETT JM
LIEBMAN HA
BERNSTEINSINGER M
ESPINA BM
CABRAL L
ALLEN S
KORNBLAU S
PIKE MC
LEVINE AM
Citation: Ps. Gill et al., TREATMENT OF ADULT T-CELL LEUKEMIA-LYMPHOMA WITH A COMBINATION OF INTERFERON-ALFA AND ZIDOVUDINE, The New England journal of medicine, 332(26), 1995, pp. 1744-1748
Authors:
GRASELA TH
WALAWANDER CA
BELTANGADY M
KNUPP CA
MARTIN RR
DUNKLE LM
BARBHAIYA RH
PITTMAN KA
DOLIN R
VALENTINE FT
LIEBMAN HA
Citation: Th. Grasela et al., ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE, The Journal of infectious diseases, 169(6), 1994, pp. 1250-1255
Authors:
LIEBMAN HA
Citation: Ha. Liebman, PLASMA OF PATIENTS TAKING COUMADIN CONTAINS PARTIALLY CABROXYLATED FACTOR-IX SPECIES FUNCTIONALLY INACTIVE, BUT RETAIN PHOSPHOLIPID-BINDING, Blood, 84(10), 1994, pp. 10000066-10000066
Authors:
POLONSKY M
LIEBMAN HA
Citation: M. Polonsky et Ha. Liebman, FACTOR-IX BINDING TO THE ENDOTHELIAL-CELL RECEPTOR IS CALCIUM-DEPENDENT, BUT CONFORMATIONAL INDEPENDENT, Blood, 84(10), 1994, pp. 10000193-10000193
Authors:
WEITZ IC
LIEBMAN HA
Citation: Ic. Weitz et Ha. Liebman, DES-GAMMA-CARBOXY (ABNORMAL) PROTHROMBIN AND HEPATOCELLULAR-CARCINOMA- A CRITICAL-REVIEW, Hepatology, 18(4), 1993, pp. 990-997
Authors:
ERON JJ
CHOW YK
CALIENDO AM
VIDELER J
DEVORE KM
COOLEY TP
LIEBMAN HA
KAPLAN JC
HIRSCH MS
DAQUILA RT
Citation: Jj. Eron et al., POL MUTATIONS CONFERRING ZIDOVUDINE AND DIDANOSINE RESISTANCE WITH DIFFERENT EFFECTS IN-VITRO YIELD MULTIPLY RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN-VIVO, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1480-1487
Authors:
WEITZ IC
LIEBMAN HA
Citation: Ic. Weitz et Ha. Liebman, CHARACTERIZATION OF THE THROMBIN TIME INHIBITOR IN AL-AMYLOIDOSIS, Blood, 82(10), 1993, pp. 10000601-10000601
Risultati:
1-13
|